Low dose colchicine for secondary prevention of cardiovascular disease - Journal of the American College of Cardiology - 2013

Brief Summary:

The addition of colchicine 0.5 mg/day to standard secondary prevention treatment with aspirin/clopidogrel and high-dose statins decreased the risk of cardiovascular events in patients with stable coronary disease. However, this trial was limited by its poor design.

Reference: http://www.ncbi.nlm.nih.gov/pubmed/23265346